# K061711: Oasis Wound Matrix

- Pathway: 510(k) (Special)
- Applicant: Cook Biotech, Inc.
- Decided: Jul 19, 2006 after 30 days
- Product code: KGN (Wound Dressing With Animal-Derived Material(S))
- Device class: U
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
No predicates in its family tree.
79 later devices descend from it; 16 cite it directly.
0 of 80 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- None. The FDA summary names no predicate by number.

## Most influential descendants
- K083440: Primatrix Dermal Repair Scaffold (2008), 20 descendants of its own
- K092096: Endoform Dermal Template (2010), 19 descendants of its own
- K140510: Miromatrix Wound Matrix (2014), 9 descendants of its own
- K152033: Cook ECM Powder (2015), 7 descendants of its own
- K100261: Primatrix AG Antimicrobial Dermal Dermal Repair Scaffold (2010), 6 descendants of its own

## Indications for use
The Oasis Wound Matrix is intended for the management of wounds including: - Partial and full thickness wounds; - Pressure ulcers; - Venous ulcers; - Diabetic ulcers; - Chronic vascular ulcers; - Tunneled, undermined wounds; - Surgical wounds (donor sites/grafts, post-Moh's surgery, post-laser surgery, podiatric, wound dehiscence); - Trauma wounds (abrasions, lacerations, second-degree burns, and skin tears); - Draining wounds. The device is intended for one-time use.

Source page: https://510kreport.com/device/K061711
Methodology: https://510kreport.com/methodology